Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial

Barbara Jacoby • May 03, 2023

By: Birgitte V. Offersen, MD, PhD; Jan Alsner, MSc, PhD; Hanne M. Nielsen, MD, PhD; Erik H. Jakobsen, MD; Mette H. Nielsen, MD, PhD; Lars Stenbygaard, MD; Anders N. Pedersen, MD, PhD; Mette S. Thomsen, MSc, PhD; Esben Yates, MSc; Martin Berg, MSc; Ebbe L. Lorenzen, MSc, PhD; Ingelise Jensen, MSc; Mirjana Josipovic, MSc, PhD; Maj-Britt Jensen, MSc; and Jens Overgaard, MD, DMSc; on behalf of the Danish Breast Cancer Group Radiotherapy Committee – Journal of Clinical Oncology

From: medpagetoday.com

Purpose

On the basis of low risk of local recurrence in elderly patients with breast cancer after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast Cancer Group initiated the noninferiority external-beam partial breast irradiation (PBI) trial (ClinicalTrials.gov identifier: NCT00892814 ). We hypothesized that PBI was noninferior to WBI regarding breast induration.

Methods

Patients operated with breast conservation for relatively low-risk breast cancer were randomly assigned to WBI versus PBI, and all had 40 Gy/15 fractions. The primary end point was 3-year grade 2-3 breast induration.

Results

In total, 865 evaluable patients (434 WBI and 431 PBI) were enrolled between 2009 and 2016. Median follow-up was 5.0 years (morbidity) and 7.6 years (locoregional recurrence). The 3-year rate of induration was 9.7% for WBI and 5.1% for PBI ( P =0.014). Large breast size was significantly associated with induration with a 3-year incidence of 13% (WBI) and 6% (PBI) for large-breasted patients versus 6% (WBI) and 5% (PBI) for small-breasted patients. PBI showed no increased risk of dyspigmentation, telangiectasia, edema, or pain, and patient satisfaction was high. Letrozole and smoking did not increase the risk of radiation-associated morbidity. Sixteen patients had a locoregional recurrence (six WBI and 10 PBI; P =0.28), 20 patients had a contralateral breast cancer, and eight patients had distant failure (five WBI and three PBI). A nonbreast second cancer was detected in 73 patients (8.4%), and there was no difference between groups.

Conclusion

External-beam PBI for patients with low-risk breast cancer was noninferior to WBI in terms of breast induration. Large breast size was a risk factor for radiation-associated induration. Few recurrences were detected and unrelated to PBI.

Read an interview about the study here .

Read the full article

Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial

 

By Barbara Jacoby 03 May, 2023
I purposely titled this as a statement rather than a question because most often the question is what we hear without any answers. I have been spending lots of time and effort in trying to find some of those answers and I think that I am finally beginning to have an understanding of this matter and believe me, there are ... The post Why We Don’t Have the Answers to Cure Breast Cancer appeared first on Let Life Happen.
By Barbara Jacoby 03 May, 2023
“Every new day is a dawn of a new divine order.” – Lailah Gifty Akita The post Every new day … appeared first on Let Life Happen.
By Barbara Jacoby 01 May, 2023
By: Caroline Helwick From: ascopost.com The management of early-stage triple-negative breast cancer has been evolving at a fast pace, thanks largely to the discovery that immune checkpoint blockade can be effective in this subtype. At the 2023 Miami Breast Cancer Conference, Priyanka Sharma, MD, Professor of Medicine, University of Kansas Medical Center, took a sweeping look at the data that ... The post Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy appeared first on Let Life Happen.
More Posts
Share by: